John Peet
Obstetrics & Gynecology · The Woodlands, TXNPI 1477641322
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,920 of the $5,063 with a category attached, or 77.4%. 29 manufacturers reported payments, led by AbbVie at 33.1% of the total. Reporting peaked in 2020 at $1,264 and has fallen 71.0% since, to $366 in 2025.
Across 152 payments — averaging $33.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Merz North America, Inc.$1K
- Revance Therapeutics, Inc.$358
- Mayne Pharma Commercial LLC$273
- Galderma Laboratories, L.p.$255
- Astellas Pharma US Inc$194
- plus $818 from 23 others
What the payments were for
- Speaking & faculty fees$95619%
- Food & beverage$3,92077%
- Education$1743%
- Gifts$130%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 62 | $1,678 |
| Merz North America, Inc. | 7 | $1,488 |
| Revance Therapeutics, Inc. | 7 | $358 |
| Mayne Pharma Commercial LLC | 9 | $273 |
| Galderma Laboratories, L.p. | 15 | $255 |
| Astellas Pharma US Inc | 7 | $194 |
| Myovant Sciences Inc. | 5 | $112 |
| AMAG Pharmaceuticals, Inc. | 5 | $102 |
| Avion Pharmaceuticals | 4 | $67 |
| Vertical Pharmaceuticals, LLC | 4 | $59 |
| Hologic Sales And Service, LLC | 2 | $55 |
| Ascend Therapeutics US, LLC | 3 | $48 |
| Exact Sciences | 3 | $47 |
| Therapeuticsmd, Inc. | 2 | $38 |
| Lupin Inc. | 2 | $35 |
| Johnson & Johnson | 1 | $27 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $26 |
| Acella Pharmaceuticals, LLC | 1 | $24 |
| Millicent US Inc | 1 | $19 |
| Dexcom, Inc. | 1 | $18 |
| Meditrina | 1 | $18 |
| Evofem Biosciences, Inc. | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $16 |
| Vivus LLC | 1 | $16 |
| Novo Nordisk | 1 | $16 |
| Acessa Health Inc. | 1 | $15 |
| Renovia Inc | 1 | $15 |
| Minerva Surgical, Inc | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
How this compares
$5,063 in reported general payments places this provider in the 85th percentile of 3,099 obstetrics & gynecology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Np ThyroidThyroid,pork | 18 | $1,348 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Acella Pharmaceuticals, LLCNp Thyroid | $24 | $1,34818 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,099 obstetrics & gynecology providers in Texas.
Other obstetrics & gynecology in The Woodlands
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
- Henry Garza IiiSan Antonio$258K
- Rene LunaMcAllen$257K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.